Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma
Condition(s):Glioma, Malignant; Gliosarcoma; Astrocytoma of BrainLast Updated:September 17, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Glioma, Malignant; Gliosarcoma; Astrocytoma of BrainLast Updated:September 17, 2019Unknown status
Condition(s):Breast Cancer Triple NegativeLast Updated:July 19, 2022Not yet recruiting
Condition(s):Adult Brainstem GliomaLast Updated:September 10, 2021Recruiting
Condition(s):Glioblastoma MultiformeLast Updated:November 19, 2021Completed
Condition(s):Lung Neuroendocrine Neoplasm; GEP Neuroendocrine TumorLast Updated:October 13, 2021Recruiting
Condition(s):Anaplastic Oligodendroglioma; Anaplastic OligoastrocytomaLast Updated:April 26, 2016Completed
Condition(s):Extensive Stage Small Cell Lung CancerLast Updated:November 23, 2016Unknown status
Condition(s):Glioma; GlioblastomaLast Updated:October 8, 2020Recruiting
Condition(s):Neuroendocrine CarcinomasLast Updated:October 26, 2020Completed
Condition(s):Glioblastoma; Brain TumorLast Updated:February 9, 2022Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.